Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Discoidin Domain Receptor (DDR)
    (4)
  • TAM Receptor
    (3)
  • FLT
    (2)
  • Autophagy
    (1)
  • Ephrin Receptor
    (1)
  • Trk receptor
    (1)
  • Tyrosine Kinases
    (1)
  • VEGFR
    (1)
  • c-Kit
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

ddr1/2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    11
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
DDR1/2 inhibitor-3
T2044572241813-33-0
DDR1 2 inhibitor-3 (5n) is an inhibitor of DDR1 2, with IC50 values of 9.4 nM and 20.4 nM, respectively. It is applicable in anti-inflammatory research.
  • Inquiry Price
10-14 weeks
Size
QTY
DDR1/2 inhibitor-2
T798112908756-11-4
DDR1 2 Inhibitor-2 (Example 31) serves as an inhibitor of DDR1 DDR2, exhibiting IC50 values below 100 nM. It is applicable in cancer and fibrotic disease research [1].
  • Inquiry Price
8-10 weeks
Size
QTY
DDR1-IN-2
DDR1 inhibitor 7rh
T54021429617-90-2
DDR1-IN-2 (DDR1 inhibitor 7rh) (DDR1 inhibitor 7rh) is a potent, selective, ATP-competitive Discoidin domain receptor 1 (DDR1) inhibitor (IC50: 6.8 nM in cell-free kinase assays).
  • Inquiry Price
Size
QTY
(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide
T601861934246-20-4In house
MitoBloCK-6 is an effective inhibitor of Erv1 ALR with IC50 values of 900 nM and 700 nM, respectively. Additionally, MitoBloCK-6 inhibits Erv2 (IC50=1.4 μM). It induces apoptosis in hESCs by promoting the release of cytochrome c.
  • Inquiry Price
Size
QTY
sitravatinib
MGCD516, MG516
T43491123837-84-2
Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRα β, PDGFR, and Axl.
  • Inquiry Price
Size
QTY
Sitravatinib malate
MGCD516 malate, MG-516 malate
T129252244864-88-6
Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.) , shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
  • Inquiry Price
1-2 weeks
Size
QTY
Merestinib dihydrochloride
LY 2801653 dihydrochloride, LY2801653 dihydrochloride
T158081206801-37-7
Merestinib dihydrochloride (LY2801653 dihydrochloride) is an orally available kinase inhibitor with antitumor activity that inhibits MET, AXL, RON, and MKNK1 2, and inhibits the growth of NTRK fusion-carrying tumors.
  • Inquiry Price
1-2 weeks
Size
QTY
TA-02
T46461784751-19-4
TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM.TA-02 especially inhibits TGFBR-2.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
jnk3 inhibitor-2
T608052366264-18-6
JNK3 inhibitor-2 is a potent and selective JNK3 inhibitor with IC50 values of >100 μM for JNK1, >100 μM for JNK2, and 0.25 μM for JNK3. JNK3 inhibitor-2 also inhibits DDR1 and EGFR (T790M, L858R) [1].
  • Inquiry Price
6-8 weeks
Size
QTY
S 16020-2
T70201178169-99-8
S 16020-2 is an olivacine derivative, and DNA topoisomerase II inhibitor endowed with a remarkable antitumor activity against various experimental tumors.
  • Inquiry Price
8-10 weeks
Size
QTY
VU6015929
T78622442597-56-8
VU6015929 is an inhibitor of active dual discoidin domain receptor 1 2 (DDR1 2)( IC50s of 4.67 nM and 7.39 nM, respectively).
  • Inquiry Price
Size
QTY